Answer
Yes, in its licensed advanced systemic mastocytosis indications. It may also be used alone in the maintenance phase for eligible AML patients who have achieved a complete response.
Sources for this answer
- Rydapt 25 mg soft capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.